corner-l-sm-grey

Leading the field of
Optoacoustic Imaging

corner-r-sm-grey

Leading the field of
Optoacoustic
Imaging

How can optoacoustic imaging benefit you?

Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications, for both clinical and preclinical research.

Clinical research

Following the success of OAI in preclinical research, the technology has already transitioned into clinical research use. Key areas of interest include oncology, inflammation and fibrosis. Results obtained so far support a bright future for OAI in clinical diagnosis.
Learn More

Preclinical research

In the past 5-10 years, OAI has become an established imaging modality for in vivo preclinical research. Based on its unique ability to differentiate endogenous chromophores and exogenous probes, a wide variety of applications has been successfully explored.
Learn More

How can optoacoustic imaging benefit you?

Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications, for both clinical and preclinical research.

Clinical research

Following the success of OAI in preclinical research, the technology has already transitioned into clinical research use. Key areas of interest include oncology, inflammation and fibrosis. Results obtained so far support a bright future for OAI in clinical diagnosis.
Learn More

Preclinical research

In the past 5-10 years, OAI has become an established imaging modality for in vivo preclinical research. Based on its unique ability to differentiate endogenous chromophores and exogenous probes, a wide variety of applications has been successfully explored.
Learn More
MSOT Acuity Echo
  • Imaging system for clinical research
  • Tomographic handheld real-time imaging
  • Anatomical, functional and molecular contrast
Product Page
RSOM Explorer C50
  • Optoacoustic mesoscopy system
  • Up to 10 µm resolution
  • 1-2 millimeters depth penetration
Product Page
MSOT inVision
  • Highly sensitive quantitative optoacoustic imaging
  • Automated whole-body image acquisition
  • Integrated whole-body ultrasound CT
Product Page
RSOM Explorer P50
  • Optoacoustic mesoscopy for preclinical research
  • Up to 10 µm resolution at 1-2 millimeters depth
  • Visualization of microvasculature
Product Page
MSOT Acuity Echo
  • Clinical imaging system for research and diagnosis
  • Tomographic handheld real-time imaging
  • Anatomical, functional and molecular contrast
Product Page
RSOM Explorer C50
  • Optoacoustic mesoscopy system
  • Up to 10 µm resolution
  • 1-2 millimeters depth penetration
Product Page
MSOT inVision
  • Highly sensitive quantitative optoacoustic imaging
  • Automated whole-body image acquisition
  • Integrated reflection-and transmission ultrasound CT
Product Page
RSOM Explorer P50
  • Optoacoustic mesoscopy for preclinical research
  • Up to 10 µm resolution at 1-2 millimeters depth
  • Visualization of microvasculature
Product Page
Previous slide
Next slide

Upcoming Events

Imaging in NMD | MYO-MRI 2023
5.11.2023 - 7.11.2023 // Berlin (Germany)
VEITHsymposium | VEITH 2023
14.11.2023 - 18.11.2023 // New York (USA)
Show more Events

Upcoming Events

Imaging in NMD | MYO-MRI 2023
5.11.2023 - 7.11.2023 // Berlin (Germany)
VEITHsymposium | VEITH 2023
14.11.2023 - 18.11.2023 // New York (USA)
Show more Events

Latest News

iThera Medical announced as a ‘Top Presenting Company’ by Tech Tour

December 29, 2022

For nearly 20 years, Tech Tour has built a community of innovative professionals focused on emerging technologies across Europe. Recently, Tech Tour selected iThera Medical as one of the top companies in 2022.

Read More »

iThera Medical closes €13 Million financing to fund translation of their optoacoustic imaging technology into routine clinical use

December 21, 2022

Medical device company iThera Medical announces successful closure of €13 Million investment round, led by TRUMPF Venture with participation by the EIC Fund as co-investor in addition to existing investors Mey Capital Matrix, Wachstumsfonds Bayern, BayBG, Fluxunit, Falk Strascheg Holding, and Occident. The funding will drive the company’s continued innovation and commercialization of its novel medical imaging technology, with a specific goal to translate the technology into a routine clinical environment and offer clinicians worldwide a powerful new diagnostic tool.

Read More »
Show more News

Recent Webinars

Show more Webinars

Contact us

If you have any questions about our technology, applications or products, don’t hesitate to get in touch.

+49 (0) 89 700 7449-21

Address Zielstattstrasse 13, 81379 Munich, Germany

Email info@ithera-medical.com

Send Message